Dyne Therapeutics DYN
NASDAQ DYN
$17.99 +0.07 (+0.39%)
As of: Nov 11, 2026 · 3:59 PM EST

Dyne Therapeutics (DYN) Long-Term Debt Issuances (2020 - 2025)

Updated

Dyne Therapeutics (DYN) recorded Long-Term Debt Issuances of $49.45 million in Q4 2025.

Analysis

Dyne Therapeutics (DYN) Long-Term Debt Issuances (2020 - 2025) Analysis & Trends

For FY2025, Dyne Therapeutics reported Long-Term Debt Issuances of $148.26 million.

  • Annual Long-Term Debt Issuances has a five-year compound annual growth rate of 71.7% (FY2020 to FY2025).
  • The Q4 2025 figure is the lowest quarterly Long-Term Debt Issuances since Q1 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Dyne Therapeutics 3.36 Bn -757.60 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 49.45 Mn
Mar 31, 2020 9.94 Mn
API Access

Dyne Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=DYN&period=max&api_key=YOUR_API_KEY